Ha Noi Pharma JSC (HSTC:DHN) Current Ratio: 0.00 (As of . 20)


HSTC:DHN Ha Noi Pharma JSC HSTC:DHN
25 GF Score
Price ₫18,900.00
View Full Analysis

What is Ha Noi Pharma JSC Current Ratio?

Ha Noi Pharma JSC HSTC:DHN +14.55% 25 Current Ratio is 0.00 as of . 20. GuruFocus rates HSTC:DHN with a GF Score™ of 25/100. Among 996 Drug Manufacturers companies, Ha Noi Pharma JSC ranks worse than 100401.51% on this metric.

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Ha Noi Pharma JSC's current ratio for the quarter that ended in . 20 was 0.00.

Ha Noi Pharma JSC has a current ratio of 0.00. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If Ha Noi Pharma JSC has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.

The historical rank and industry rank for Ha Noi Pharma JSC's Current Ratio or its related term are showing as below:

HSTC:DHN's Current Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2
* Ranked among companies with meaningful Current Ratio only.

Ha Noi Pharma JSC  (HSTC:DHN) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Ha Noi Pharma JSC Current Ratio Related Terms


Ha Noi Pharma JSC Current Ratio Historical Data

* Premium members only.

The historical data trend for Ha Noi Pharma JSC's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ha Noi Pharma JSC Current Ratio Chart

Ha Noi Pharma JSC Annual Data
Trend
Current Ratio

Ha Noi Pharma JSC Semi-Annual Data
Current Ratio

HSTC:DHN vs : Current Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ha Noi Pharma JSC's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ha Noi Pharma JSC Current Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ha Noi Pharma JSC's Current Ratio distribution charts can be found below:

* The bar in red indicates where Ha Noi Pharma JSC's Current Ratio falls into.


HSTC:DHN
25GF Score
Ha Noi Pharma JSC HSTC:DHN
Current Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ha Noi Pharma JSC Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Ha Noi Pharma JSC's Current Ratio for the fiscal year that ended in . 20 is calculated as

Current Ratio (A: . 20 )=Total Current Assets (A: . 20 )/Total Current Liabilities (A: . 20 )
=/
=

Ha Noi Pharma JSC's Current Ratio for the quarter that ended in . 20 is calculated as

Current Ratio (Q: . 20 )=Total Current Assets (Q: . 20 )/Total Current Liabilities (Q: . 20 )
=/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Current Ratio →
What does a Current Ratio of 0.00 mean?
Ha Noi Pharma JSC (HSTC:DHN) has a Current Ratio of 0.00 as of . 20. According to the industry distribution chart, Ha Noi Pharma JSC ranks #999999 out of 996 companies in the Drug Manufacturers industry.
Is Ha Noi Pharma JSC's Current Ratio too high?
Ha Noi Pharma JSC's current Current Ratio is 0.00. Based on the distribution chart, Ha Noi Pharma JSC ranks #999999 out of 996 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Ha Noi Pharma JSC has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Ha Noi Pharma JSC's Current Ratio compare to ?
According to the Drug Manufacturers industry distribution chart, Ha Noi Pharma JSC ranks #999999 out of 996 companies for Current Ratio. This places Ha Noi Pharma JSC in the lower half of its industry. The industry median Current Ratio is 2.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Drug Manufacturers company?
The median Current Ratio among Drug Manufacturers companies is 2.00, based on 996 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Current Ratio is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ha Noi Pharma JSC's current Current Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ha Noi Pharma JSC stock overvalued right now?
Ha Noi Pharma JSC (HSTC:DHN) has a current Current Ratio of 0.00. The current Current Ratio is 0.00. Ha Noi Pharma JSC's overall GF Score™ is 25/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Ha Noi Pharma JSC (HSTC:DHN), the current Current Ratio is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ha Noi Pharma JSC Business Description

Comparable Companies
Address 170 La Thanh, O cho Dua ward, Dong Da district, Ha Noi city, VNM
Ha Noi Pharma JSC is engaged in the producing, trading, and importing of drugs. Some of its products are Bratorex, Polytincol, Gentamicin, and others.
25GF Score

Get the complete analysis for HSTC:DHN

Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫18,900.00
Price